Juan Daniel Castillo Gomez

Juan Daniel Castillo Gomez

Auto-generated profile, based on publicly available information

Juan Daniel Castillo Gomez

University of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute of Diagnostic and Interventional Radiology, Cologne, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Theranostics
Verified
Journal Article
Open access
SESarah Erdmann
Sarah Erdmann
LNLars Niederstadt
Lars Niederstadt
EKEva Jolanthe Koziolek
Eva Jolanthe Koziolek
JGJuan Daniel Castillo Gómez
Juan Daniel Castillo Gómez
SPSonal Prasad
Sonal Prasad
Carsten GrötzingerCarsten Grötzinger
Carsten Grötzinger
Background: Molecular targeting remains to be a promising approach in oncology. Overexpression of G protein-coupled receptors (GPCRs) in human cancer is offering a powerful opportunity for tumor-selective imaging and treatment employing nuclear medicine. We utilized novel chemerin-based peptide conjugates for chemokine-like receptor 1 (CMKLR1) targeting in a breast cancer xenograft model.

1 December 2012 in Inorganic Chemistry Communications
Verified
Journal Article
Closed access
HNHung Huy Nguyen
Hung Huy Nguyen
JGJuan Daniel Castillo Gomez
Juan Daniel Castillo Gomez
UAUlrich Abram
Ulrich Abram

15 November 2016 in European Journal of Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
CGCastillo Gomez
Castillo Gomez
JDJuan Daniel
Juan Daniel
AHAdelheid Hagenbach
Adelheid Hagenbach
UAUlrich Abram
Ulrich Abram

1 January 2021 in International Journal of Hyperthermia
Verified
Journal Article
Open access
LSLukas Christian Sebeke
Lukas Christian Sebeke
PRPia Rademann
Pia Rademann
AMAlexandra Claudia Maul
Alexandra Claudia Maul
SYSin Yuin Yeo
Sin Yuin Yeo
JGJuan Daniel Castillo Gómez
Juan Daniel Castillo Gómez
EHEdwin Heijman
Edwin Heijman
This article will report results from the in-vivo application of a previously published model-predictive control algorithm for MR-HIFU hyperthermia. The purpose of the investigation was to test the...

1 August 2012 in Polyhedron
Verified
Journal Article
Closed access
JGJuan Daniel Castillo Gomez
Juan Daniel Castillo Gomez
HNHung Huy Nguyen
Hung Huy Nguyen
AHAdelheid Hagenbach
Adelheid Hagenbach
UAUlrich Abram
Ulrich Abram

1 January 2020 in International Journal of Hyperthermia
Verified
Journal Article
Open access
LSLukas Christian Sebeke
Lukas Christian Sebeke
PRPia Rademann
Pia Rademann
AMAlexandra Claudia Maul
Alexandra Claudia Maul
CSClaudia Schubert-Quecke
Claudia Schubert-Quecke
TAThorsten Annecke
Thorsten Annecke
EHEdwin Heijman
Edwin Heijman
Purpose: Pancreatic cancer is typically diagnosed in a late stage with limited therapeutic options. For those patients, ultrasound-guided high-intensity focused ultrasound (US-HIFU) can improve local control and alleviate pain. However, MRI-guided HIFU (MR-HIFU) has not yet been studied extensively in this context. To facilitate related research and accelerate clinical translation, we report a workflow for the in vivo HIFU ablation of the porcine pancreas under MRI guidance. Materials and methods: The pancreases of five healthy German landrace pigs (35–58 kg) were sonicated using a clinical MR-HIFU system. Acoustic access to the pancreas was supported by a specialized diet and a hydrogel compression device for bowel displacement. Organ motion was suspended using periods of apnea. The size of the resulting thermal lesions was assessed using the thermal threshold- and dose profiles, non-perfused volume, and gross examination. The effect of the compression device on beam path length was assessed using MRI imaging. Results: Eight of ten treatments resulted in clearly visible damage in the target tissue upon gross examination. Five treatments resulted in coagulative necrosis. Good agreement between the four metrics for lesion size and a clear correlation between the delivered energy dose and the resulting lesion size were found. The compression device notably shortened the intra-abdominal beam path. Conclusions: We demonstrated a workflow for HIFU treatment of the porcine pancreas in-vivo under MRI-guidance. This development bears significance for the development of MR-guided HIFU interventions on the pancreas as the pig is the preferred animal model for the translation of pre-clinical research into clinical application.